SCLX
Scilex Holding Company
NASDAQ · USHealthcareDrug Manufacturers - General
$7.64-9.48%
Price as of Jul 20, 2026
SCLX profitability
Scilex Holding Company profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 55.0%
- EBITDA margin
- -1105.5%
- EBIT margin
- -817.1%
- Net margin
- -1239.4%
- Free cash flow margin
- -19.5%
Returns
- Return on equity
- 168.4%
- Return on assets
- -142.9%
- Return on invested capital
- 193.7%
- Asset turnover
- 0.10x
Cash efficiency
- Cash from operations
- -$3.7M
- Cash per share
- $0.40
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.